Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Aspen Aerogels, Inc. Reports Third Quarter 2016 Financial Results and Recent Business Developments


      News provided by

      Aspen Aerogels, Inc.

      Nov 03, 2016, 04:15 ET

      Share this article

      Share this article


      NORTHBOROUGH, Mass., Nov. 3, 2016 /PRNewswire/ -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen Aerogels") today announced financial results for its third quarter of 2016, which ended September 30, 2016, and discussed business developments during the quarter.

      Total revenue for the quarter of $29.6 million decreased by 6% compared to the third quarter last year. Third quarter net loss increased to $3.1 million compared to a net loss of $2.5 million in the third quarter of 2015. Net loss per share for the quarter was $0.13 compared to a net loss of $0.11 in the third quarter of 2015.

      Adjusted EBITDA for the third quarter of 2016 was $1.5 million compared to $1.7 million in the third quarter of 2015. A reconciliation of non-GAAP Adjusted EBITDA to net loss is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading "Non-GAAP Financial Measures."

      Net loss and Adjusted EBITDA included $1.1 million during the third quarter of 2016 and $0.2 million during the third quarter of 2015 of legal and related expenses associated with Aspen Aerogels' ongoing patent enforcement actions at the U.S. International Trade Commission and in the German courts.

      Third Quarter 2016 Business Developments

      • Gross profit increased 24% year-over-year to $6.4 million, with a gross margin of 22%
      • Completed and commissioned the East Providence pilot line
      • Adjusted timing of the Statesboro, Georgia manufacturing facility and related financing

      "We operated well in the third quarter, despite the anticipated weakness in the upstream energy markets. We achieved solid improvement in gross profit and the modest declines in net income and Adjusted EBITDA were driven primarily by the increase in expense associated with our patent enforcement actions. Record revenues in the Asian market, led by continued shipments to the South Asia petrochemical project, were offset by recent softness in the North American and European downstream markets," said Don Young, President and CEO of Aspen Aerogels.

      "Looking forward, we anticipate that the general uncertainty in the energy markets and recent weakness in the downstream markets will continue into 2017. With this view of the market, we believe that we could be challenged to maintain our business levels. Accordingly, we have decided to temporarily delay the board approved Statesboro, Georgia manufacturing expansion and its related financing to better align the expansion project with our assessment of demand for the 2018 to 2020 period," continued Mr. Young.

      "We made solid progress during the quarter in our efforts to diversify our markets and to expand the reach of our technology. We saw strong growth in the LNG and district energy markets and remain on track to introduce products optimized for the power market in late 2017. We completed construction and commenced operation of the pilot line in our East Providence facility designed to support the creation of next generation products for both new and existing markets. In addition, we commenced work on our joint development initiatives with BASF with an initial focus on the building materials market, and continued to seek partnerships with other market leaders to expand the reach of our aerogel technology platform. We believe these initiatives, investments and partnerships will position Aspen for strong long-term growth, particularly when the energy market stabilizes," concluded Mr. Young.

      2016 Financial Outlook

      Aspen Aerogels updates its 2016 full year outlook as follows:

      • Total revenue is expected to range between $118 million and $121 million, a refinement of prior guidance of $117 million to $125 million
      • Net loss is expected to range between $9.4 million and $10.6 million, down from the prior guidance range of $6.8 million to $8.6 million
      • Adjusted EBITDA is expected to range between $5.4 million and $6.4 million, down from the prior guidance range of $7.0 million to $8.5 million
      • Net loss per share is expected to range between $0.41 and $0.46, down from the prior guidance range of $0.30 to $0.37 per share

      Our updated 2016 outlook also assumes depreciation and amortization of between $9.7 million and $9.8 million, stock compensation expense of between $5.3 million and $5.4 million, interest and other expense of $0.8 million, and weighted average shares outstanding of 23.2 million for the full year. In addition, our updated 2016 outlook reflects an expected $3.5 million to $3.7 million of costs and expenses associated with our patent enforcement actions for the year.

      A reconciliation of non-GAAP Adjusted EBITDA to net loss for this 2016 financial outlook is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading "Non-GAAP Financial Measures."

      Aspen Aerogels may incur charges, realize gains or losses, incur financing costs or interest expense, or experience other events in 2016 that could cause actual results to vary materially from this outlook. In addition, the timing of projects may have a significant impact on quarterly and annual revenue and profitability and can be difficult to predict.

      Conference Call Notification

      A conference call with Aspen Aerogels management to discuss the third quarter results and business developments will be webcast at 5:00 pm EDT on November 3, 2016. During the call, management will respond to questions concerning, but not limited to, Aspen Aerogels' financial performance, business conditions and industry outlook. Management's discussion and responses could contain information that has not been previously disclosed. The conference call will be available live as a listen-only webcast and will be hosted at the Investors section of the Aspen Aerogels website, www.aerogel.com. In addition, you may call 866-393-4306 (toll free, U.S. & Canada only) passcode "98708857", or +1 734-385-2616 (international) passcode "98708857", to listen to the live webcast.

      Following the live event, an archived version of the webcast will be available on the Aspen Aerogels website for convenient on-demand replay.

      A copy of this press release is posted in the Investors section on the Aspen Aerogels website.

      Non-GAAP Financial Measures

      In addition to providing financial measurements based on generally accepted accounting principles in the United States of America ("GAAP"), Aspen Aerogels provides additional financial metrics that are not prepared in accordance with GAAP ("non-GAAP").  The non-GAAP financial measure included in this press release is Adjusted EBITDA. Management uses non-GAAP financial measures, in addition to GAAP financial measures, as a measure of operating performance because the non-GAAP financial measures do not include the impact of items that management does not consider indicative of Aspen Aerogels' core operating performance. In addition, management uses Adjusted EBITDA (i) for planning purposes, including the preparation of Aspen Aerogels' annual operating budget, (ii) to allocate resources to enhance the financial performance of its business, and (iii) as a performance measure under its bonus plan.

      Management believes that these non-GAAP financial measures reflect Aspen Aerogels' ongoing business in a manner that allows for meaningful comparisons and analysis of trends in its business, as they exclude expenses and gains not reflective of Aspen Aerogels' ongoing operating results or that may be infrequent and/or unusual in nature. Management also believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating Aspen Aerogels' operating results and future prospects in the same manner as management and in comparing financial results across accounting periods and to those of peer companies. These non-GAAP measures may not be comparable to similarly titled measures presented by other companies.

      The non-GAAP financial measures do not replace the presentation of Aspen Aerogels' GAAP financial results and should only be used as a supplement to, not as a substitute for, Aspen Aerogels' financial results presented in accordance with GAAP. In this press release, Aspen Aerogels has provided a reconciliation of Adjusted EBITDA to net income (loss), the most directly comparable GAAP financial measure. Management strongly encourages investors to review Aspen Aerogels' financial statements and publicly-filed reports in their entirety and not rely on any single financial measure.

      About Aspen Aerogels, Inc.

      Aspen Aerogels is an aerogel technology company that designs, develops and manufactures innovative, high-performance aerogel insulation used primarily in the energy infrastructure and building materials markets where thermal energy efficiency is at a premium and Aspen's products offer unique value. Headquartered in Northborough, Mass., Aspen Aerogels manufactures its Cryogel®, Pyrogel® and Spaceloft® products at its East Providence, R.I. facility.

      Investor Relations Contact:
      Shawn Severson
      EnergyTech Investor, LLC
      Phone: (415) 233-7094
      [email protected]

      Special Note Regarding Forward-Looking and Cautionary Statements

      This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements, including statements relating to Aspen Aerogels' 2016 Financial Outlook. These statements are not historical facts but rather are based on Aspen Aerogels' current expectations, estimates and projections regarding Aspen Aerogels' business, operations and other factors relating thereto, including with respect to the 2016 Financial Outlook. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates," "outlook,"  and similar expressions are used to identify these forward-looking statements. Such forward-looking statements include statements regarding, among other things, Aspen Aerogels' expectations about revenue, expenses, Adjusted EBITDA and GAAP EPS; beliefs about Aspen Aerogels financial health and capacity to fund operations; beliefs about Aspen Aerogels' strategic partnership with BASF, including the potential for the supply agreement and joint development agreement to create new product and market opportunities and to assist in Aspen Aerogel's market diversification and growth strategy; beliefs about the general strength or health of Aspen Aerogels' business; beliefs about current or future trends in the energy markets, and the impact of these trends on Aspen Aerogels' business; beliefs about Aspen Aerogels' technology strategy and implementation; beliefs about the benefits of the pilot line in the East Providence, Rhode Island, facility, future operating performance on an annual or other basis; accounting and other assumptions involved in arriving at the expectations; and expectations about the cost, timing or likelihood of success of Aspen Aerogels' patent enforcement actions. All such forward-looking statements are based on management's present expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the following:  any inability by Aspen Aerogels or BASF to achieve the goals of the strategic partnership, including an inability to create meaningful revenue under the supply agreement, and an inability to create new product and market opportunities, including in the building materials market; any failure to operate or maintain the pilot line; any sustained downturn in the energy industry or energy prices; any disruption or inability to achieve expected capacity levels in any of our three production lines or the manufacturing facility in which they are located; any failure of demand for Aspen Aerogels' products; any failure to achieve expected average selling prices for Aspen Aerogels' products; the failure to generate sufficient operating cash flow or to obtain significant additional capital to pursue Aspen Aerogels' strategy; the failure of our products to become widely adopted; the competition Aspen Aerogels faces in its business; any failure of Aspen Aerogels' products to meet applicable specifications and other performance, safety, technical and delivery requirements; the general economic conditions and cyclical demands in the markets that Aspen Aerogels serves; the economic, operational and political risks associated with sales and expansion of operations in foreign countries; the loss of any direct customer, including distributors, contractors and OEMs; compliance with health and safety laws and regulations; shortages of raw materials; the maintenance and development of distribution channels; and the other risk factors discussed under the heading "Risk Factors" contained in our Annual Report on Form 10-K for the year ended December 31, 2015 and filed with the Securities and Exchange Commission ("SEC")  on March 4, 2016, as well as any updates to those risk factors filed from time to time in our subsequent periodic and current reports filed with the SEC. All statements contained in this press release are made only as of the date of this press release, and Aspen Aerogels does not intend to update this information unless required by law.

      ASPEN AEROGELS, INC.

      Condensed Consolidated Balance Sheets

      (Unaudited and in thousands)








      September 30,


      December 31,



      2016


      2015






      Assets





      Current assets:





      Cash and cash equivalents


      $         21,129


      $         32,804

      Accounts receivable, net


      19,625


      20,624

      Inventories


      12,902


      6,532

      Prepaids and other current assets


      1,831


      1,687

      Total current assets


      55,487


      61,647

      Property, plant, and equipment, net


      81,905


      78,322

      Other assets


      79


      105

      Total assets


      $       137,471


      $       140,074






      Liabilities and Stockholders' Equity





      Current liabilities:





      Accounts payable


      $         11,544


      $         10,684

      Accrued expenses


      4,145


      5,568

      Deferred revenue


      753


      681

      Other current liabilities


      41


      476

      Total current liabilities


      16,483


      17,409

      Other long-term liabilities


      714


      191

      Total liabilities


      17,197


      17,600

      Total stockholders' equity


      120,274


      122,474

      Total liabilities and stockholders' equity


      $       137,471


      $       140,074







      ASPEN AEROGELS, INC.

      Consolidated Statements of Operations

      (Unaudited and In thousands, except share and per share data)













      Three Months Ended



      Nine Months Ended



      September 30,



      September 30,













      2016


      2015



      2016


      2015











      Revenue:










      Product


      $     28,877


      $     30,926



      $     88,286


      $     83,891

      Research services


      683


      613



      1,813


      1,243

      Total revenue


      29,560


      31,539



      90,099


      85,134

      Cost of revenue:










      Product


      22,790


      26,017



      69,505


      69,676

      Research services


      368


      350



      1,012


      663

      Gross profit


      6,402


      5,172



      19,582


      14,795

      Operating expenses:










      Research and development


      1,328


      1,146



      3,924


      4,001

      Sales and marketing


      3,056


      2,793



      8,939


      7,847

      General and administrative


      4,422


      3,709



      12,229


      10,866

      Total operating expenses


      8,806


      7,648



      25,092


      22,714

      Loss from operations


      (2,404)


      (2,476)



      (5,510)


      (7,919)











      Interest expense, net


      (37)


      (46)



      (115)


      (136)

      Postponed financing costs


      (656)


      -



      (656)


      -

      Total other expense, net


      (693)


      (46)



      (771)


      (136)











      Net loss:


      $     (3,097)


      $     (2,522)



      $     (6,281)


      $     (8,055)











      Net loss per share:




















      Basic


      $       (0.13)


      $       (0.11)



      $       (0.27)


      $       (0.35)











      Diluted


      $       (0.13)


      $       (0.11)



      $       (0.27)


      $       (0.35)











      Weighted-average common shares outstanding:




















      Basic and diluted


      23,168,251


      23,060,456



      23,114,280


      23,017,822











          

      Square Foot Operating Metric

      We price our product and measure our product shipments in square feet.


      Three Months Ended


      Nine Months Ended


      September 30,


      September 30,










      2016


      2015


      2016


      2015










      (amounts in thousands)









      Product shipments in square feet

      11,843


      10,450


      33,632


      30,380

      Reconciliation of Non-GAAP Financial Measures  

      The following table presents a reconciliation of the non-GAAP financial measure included in the Aspen Aerogels, Inc. press release dated November 3, 2016 to the most directly comparable GAAP measure:

      Reconciliation of Adjusted EBITDA to Net Income (Loss)

      We define Adjusted EBITDA as net income (loss) before interest expense, taxes, depreciation, amortization, stock-based compensation expense and other items, which occur from time to time, which recently included postponed financing costs, which we do not believe are indicative of our core operating performance.

      For the three and nine months ended September 30, 2016 and 2015:




      Three Months Ended


      Nine Months Ended




      September 30,


      September 30,














      2016


      2015


      2016


      2015














      (amounts in thousands)











      Net loss


      $      (3,097)


      $      (2,522)


      $      (6,281)


      $      (8,055)


      Depreciation and amortization

      2,472


      2,664


      7,298


      7,422


      Stock-based compensation

      1,474


      1,476


      4,277


      4,175


      Postponed financing costs

      656


      -


      656


      -


      Interest expense, net

      37


      46


      115


      136













      Adjusted EBITDA

      $       1,542


      $       1,664


      $       6,065


      $       3,678











      For the 2016 full year financial outlook:




      Year Ending




      December 31, 2016










      Low


      High










      (amounts in thousands)        







      Net loss


      $    (10,600)


      $      (9,400)


      Depreciation and amortization

      9,800


      9,700


      Stock-based compensation

      5,400


      5,300


      Postponed financing costs

      700


      700


      Interest expense, net

      100


      100









      Adjusted EBITDA

      $       5,400


      $       6,400







      SOURCE Aspen Aerogels, Inc.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.